NFE2L2 and esophageal squamous cell carcinoma: In an integrated dataset that consists of 1930 ESCC genomes from 33 datasets, NRF2, KEAP1, and CUL3 mutation took place in 7.62%, 2.75% and 2.49% cases, respectively.